Cargando…

The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non‐small‐cell lung cancer‐a retrospective study from one single cancer institute

BACKGROUND: Leptomeningeal metastasis (LM) is a detrimental complication of advanced non‐small‐cell lung cancer (NSCLC), and the optimal therapeutic approach for LM patients is in shortage. This retrospective study aimed to investigate the clinical features and prognostic factors of NSCLC patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Weiwei, Jing, Wang, An, Ning, Tian, Yaru, Guo, Dong, Kong, Li, Zhu, Hui, Yu, Jinming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558588/ https://www.ncbi.nlm.nih.gov/pubmed/30993909 http://dx.doi.org/10.1002/cam4.2156

Ejemplares similares

Prognostic significance of molecular characteristics of cerebrospinal fluid for non‐small cell lung cancer patients with leptomeningeal metastasis
por: Li, Ning, et al.
Publicado: (2019)

VLA-4 suppression by senescence signals regulates meningeal immunity and leptomeningeal metastasis
por: Li, Jiaqian, et al.
Publicado: (2022)

Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer
por: Li, Qing, et al.
Publicado: (2022)

Prognostic impacts of extracranial metastasis on non‐small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database
por: Wang, Miao, et al.
Publicado: (2020)

Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single‐arm study
por: Pan, Zhenyu, et al.
Publicado: (2016)

Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis
por: Yan, Weiwei, et al.
Publicado: (2019)

Clinical outcomes of immune checkpoint blockades and the underlying immune escape mechanisms in squamous and adenocarcinoma NSCLC
por: Tian, Yaru, et al.
Publicado: (2020)

The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer
por: Liu, Wenli, et al.
Publicado: (2021)

Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases
por: Jaeckle, Kurt A., et al.
Publicado: (2020)

Treatment Outcome and Prognostic Factors for Patients with Bone-Only Metastases of Breast Cancer: A Single-Institution Retrospective Analysis
por: Niikura, Naoki, et al.
Publicado: (2011)

The Riddle of the Sphinx: Progress in Leptomeningeal Metastasis of Non–Small Cell Lung Cancer
por: Zhao, Yuhua, et al.
Publicado: (2023)

Leptomeningeal carcinomatosis from gastric cancer: single institute retrospective analysis of 9 cases
por: Kim, Nam-Hee, et al.
Publicado: (2014)

Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival
por: Niwińska, Anna, et al.
Publicado: (2013)

Risk factors for brain metastases in patients with non–small‐cell lung cancer
por: An, Ning, et al.
Publicado: (2018)

Axon-like protrusions promote small cell lung cancer migration and metastasis
por: Yang, Dian, et al.
Publicado: (2019)

Leptomeningeal Metastasis in Gliomas : Clinical Characteristics and Risk Factors
por: Yang, Jeyul, et al.
Publicado: (2023)

In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma
por: Lvu, Wen, et al.
Publicado: (2020)

41. PROGNOSTIC VALIDATION OF THE EANO ESMO CLASSIFICATION OF LEPTOMENINGEAL METASTASIS
por: Le Rhun, Emilie, et al.
Publicado: (2020)

Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers
por: Naidoo, Jarushka, et al.
Publicado: (2021)

Leptomeningeal metastasis in breast cancer – a systematic review
por: Scott, Brian J., et al.
Publicado: (2015)

A case report of prostate cancer with leptomeningeal metastasis
por: Dehghani, Mansoureh, et al.
Publicado: (2021)

Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer
por: Sun, Lin, et al.
Publicado: (2020)

Survival Outcomes of Patients With Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
por: Li, Ning, et al.
Publicado: (2022)

A Retrospective Study of Intrathecal Pemetrexed Combined With Systemic Therapy for Leptomeningeal Metastasis of Lung Cancer
por: Geng, Di, et al.
Publicado: (2022)

Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis
por: Zhang, Jing, et al.
Publicado: (2020)

Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer
por: Yan, Peng, et al.
Publicado: (2021)

Durable clinical benefit of letrozole in leptomeningeal metastasis of breast cancer
por: Takanashi, Toshihiro, et al.
Publicado: (2019)

Leptomeningeal Carcinomatosis With Optic Nerve Metastasis Secondary to Breast Cancer
por: Chew, Chiachee, et al.
Publicado: (2021)

Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis
por: Nie, Naifu, et al.
Publicado: (2022)

Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study
por: Zhou, Tao, et al.
Publicado: (2023)

Nanoparticle albumin‐bound paclitaxel in elder patients with advanced squamous non‐small‐cell lung cancer: A retrospective study
por: Liu, Yang, et al.
Publicado: (2019)

Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes
por: Zhuang, Aojia, et al.
Publicado: (2023)

Treatment and prognostic analysis of patients with leptomeningeal metastases from non-small cell lung cancer
por: Xu, Qinghua, et al.
Publicado: (2015)

Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
por: Freeman, Meredith N, et al.
Publicado: (2022)

The roles of MASPIN expression and subcellular localization in non-small cell lung cancer
por: Wang, Xiao-Fei, et al.
Publicado: (2020)

Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value
por: Herrlinger, U, et al.
Publicado: (2004)

Transforming growth factor-β(1) induces connective tissue growth factor expression and promotes peritoneal metastasis of gastric cancer
por: Lv, Ling, et al.
Publicado: (2020)

Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer
por: Peixoto, Renata D’Alpino, et al.
Publicado: (2015)

Hemidystonia as an Initial Manifestation of Leptomeningeal Metastasis
por: Jung, Hyun-Jung, et al.
Publicado: (2009)

Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer
por: Hong, Ye, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jt83odliuv4c3u1th3k67pctn8